Stock Events

Stock Events

Alvotech 

$0.2500
20
-$0.08-24.27% Monday 18:39

Statistics

Day High
0.25
Day Low
0.25
52W High
0.25
52W Low
0.25
Volume
31
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q1 2026
Next
-0.47
-0.27
-0.06
0.14
Expected EPS
-0.024001
Actual EPS
N/A

Financials

-84.79%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
546.94MRevenue
-463.73MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 6.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
0%
Sell
50%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALVOW. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap182.21B
Amgen is a biotechnology company focused on developing novel therapeutics, including biosimilars, which directly competes with Alvotech's biosimilar product portfolio.
Pfizer
PFE
Mkt Cap143.68B
Pfizer is a global pharmaceutical company with a strong presence in the biosimilars market, making it a direct competitor to Alvotech in the biosimilar space.
Biogen
BIIB
Mkt Cap29.02B
Biogen has a focus on biologics and has ventured into the biosimilars market, positioning it as a competitor to Alvotech.
Novartis
NVS
Mkt Cap280.64B
Novartis, through its generics division Sandoz, is a leading company in the biosimilars market, competing with Alvotech in developing and marketing biosimilar products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.66B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, including biosimilars, competing with Alvotech in the biosimilar pharmaceuticals market.
Merck
MRK
Mkt Cap281.24B
Merck & Co., known as MSD outside the United States and Canada, has made strides in biosimilars, making it a competitor to Alvotech.
Abbvie
ABBV
Mkt Cap382.49B
AbbVie has a growing interest in biosimilars, particularly with its Humira biosimilar, directly competing with Alvotech's biosimilar development efforts.
Roche
RHHBY
Mkt Cap320.37B
Roche, through its Genentech unit, is involved in the development of biosimilars, competing with Alvotech in the biotechnology and biosimilars market.
Sanofi
SNY
Mkt Cap101.45B
Sanofi is expanding its presence in the biosimilars market, making it a competitor to Alvotech in the development and commercialization of biosimilar products.
Astrazeneca
AZN
Mkt Cap271.29B
AstraZeneca is involved in biopharmaceuticals and has shown interest in biosimilars, positioning it as a competitor to Alvotech in the biosimilar and biologics market.

About

Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
Show more...
CEO
Mr. Vilhelm Robert Wessman
Employees
1012
Country
United States
ISIN
LU2458333858

Listings

ST
SE
ALVO-SDB.ST
MU
DE
Z45.MU
STU
DE
Z45.STU
XNAS
US
ALVOW

0 Comments

Share your thoughts

FAQ

What is Alvotech stock price today?▼
The current price of ALVOW is $0.25 USD — it has decreased by -24.27% in the past 24 hours. Watch Alvotech stock price performance more closely on the chart.
What is Alvotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Alvotech stocks are traded under the ticker ALVOW.
When is the next Alvotech earnings date?▼
Alvotech is going to release the next earnings report on August 19, 2026.
What were Alvotech earnings last quarter?▼
ALVOW earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.05 USD resulting in a -91.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Alvotech revenue for the last year?▼
Alvotech revenue for the last year amounts to 546.94M USD.
What is Alvotech net income for the last year?▼
ALVOW net income for the last year is -463.73M USD.
How many employees does Alvotech have?▼
As of June 23, 2026, the company has 1,012 employees.
In which sector is Alvotech located?▼
Alvotech operates in the Health & Wellness sector.
When did Alvotech complete a stock split?▼
Alvotech has not had any recent stock splits.
Where is Alvotech headquartered?▼
Alvotech is headquartered in Luxembourg, United States.